glutathione and triple negative breast cancer Ratiometrically designed nanoprodrug for triple-negative treatment Activation of the eIF2α/ATF4 axis
Activation of the eIF2 ATF4 axis drives triple negative breast cancer radioresistance by promoting glutathione biosynthesis ScienceDirect Role of Glutathione in Cancer: From Mechanisms to Therapies Excessive glutathione intake contributes to chemotherapy resistance in breast cancer: a propensity score matching analysis PMC Targeting the redox programmed cell death axis in breast cancer: from molecular mechanisms to therapeutic resistance Cell Death Discovery
Pay in 4 interest-free payments of $7.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10



